Method for determining related substances of DL-lactic acid vortioxetine intermediate by liquid chromatography

Through the gradient elution procedure of high performance liquid chromatography, the problem of impurity monitoring in DL-Lactyl wotexetine intermediate was solved, the purity and yield of the drug were improved, and the quality control of DL-Lactyl wotexetine intermediate was ensured. .

CN119023822APending Publication Date: 2024-11-26BEIJING VENTUREPHARM BIOTECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310590236.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-24
Publication Date
2024-11-26

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

The invention discloses a method for determining related substances in a DL-lactic acid vortioxetine intermediate, which is characterized in that separation and detection are carried out in a gradient elution mode by adopting a high performance liquid chromatography method with a chromatographic column of C18 and a certain proportion of organic phase solution-organic phase as a mobile phase.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of chemical drug analysis, and in particular to an analysis method for analyzing and determining DL-lactate vortioxetine intermediates and related substances thereof by using liquid chromatography. Background Art

[0002] 1-Bromo-2-iodobenzene, also known as o-iodobromobenzene, has a chemical name of 1-bromo-2-iodobenzene, a molecular formula of C6H4BrI and a molecular weight of 282.9.

[0003]

[0004] If the impurities in the DL-lactate vortioxetine intermediate cannot be completely removed, side reactions will occur, which will affect the purity and quality of the drug. Therefore, separation of DL-lactate vortioxetine and other related substances is of great practical significance in the quality control of the DL-lactate vortioxetine synthesis process. Summary of the invention

[0005] The present invention provides an analysis method for related substances in a DL-lactate vortioxetine intermediate, thereby being able to quickly, effectively and accurately monitor the purity of the related substances in the DL-lactate vortioxetine intermediate and achieve quality control of the final product raw material drug.

[0006] The invention provides an analysis method for DL-vortioxetine lactate intermediate-related substances, which adopts high performance liquid chromatography, uses a C18 column as a chromatographic column, uses a certain proportion of an organic phase solution as a mobile phase A and an organic phase as a mobile phase B, and performs gradient elution.

[0007] The present invention provides a method for analyzing related substances of DL-lactate vortioxetine intermediates, wherein the gradient elution procedure is:

[0008] Preferably, a certain proportion of the organic phase solution is a 30% acetonitrile solution.

[0009] Preferably, the organic phase is methanol.

[0010] Preferably, the chromatographic column provided is ZORBAX SB-C18 (4.6 mm×250 mm, 5 µm).

[0011] The separation and determination method of the present invention can be implemented according to the following method: 1) Take an appropriate amount of o-iodobromobenzene sample, dissolve the sample in methanol, and prepare a sample solution containing 0.1~1.5 mg of o-iodobromobenzene per 1 ml.

[0012] 2) Set the mobile phase flow rate to 0.5-1.5 mL / min, preferably 1.0 mL / min, the detection wavelength to 220-240 nm, the optimal detection wavelength to 230 nm, the column oven temperature to 20-50 °C, and the optimal column oven temperature to 30 °C.

[0013] 3) Take 10-50 μl of the sample solution in 1) above and inject it into the liquid chromatograph to complete the separation and determination of o-iodobromobenzene and related substances. Wherein: High performance liquid chromatograph: Agilent 1260 InfinityII; Chromatographic column: ZORBAX SB-C18 (4.6 mm × 250 mm, 5 µm); Mobile phase A: 30% acetonitrile solution (pipette 300 ml of acetonitrile, dilute to 1000 ml with water, shake well); Mobile phase B: methanol; Elution was performed according to the following gradient:

[0014] Flow rate: 1.0 mL / min; Column temperature: 30°C; Detection wavelength: 230nm; Injection volume: 10 μl;

[0015] The invention adopts a ZORBAX SB-C18 (250×4.6 mm, 5μm) chromatographic column, which can effectively separate o-iodobromobenzene and its related substances. The invention solves the problem of separation and determination of o-iodobromobenzene and its related substances, improves the yield and purity of the product, and ensures that the quality of o-iodobromobenzene is controllable. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 This is the blank solvent HPLC chart of o-iodobromobenzene in Example 1.

[0017] Figure 2 This is the HPLC chart of the o-iodobromobenzene intermediate and its related substances in Example 1. Specific implementation method: The following examples are used to further understand the present invention, but are not intended to limit the scope of this embodiment.

[0019] Example 1 Instruments and conditions High performance liquid chromatograph: Agilent 1260 InfinityII; Chromatographic column: ZORBAX SB-C18 (4.6 mm × 250 mm, 5 µm); Mobile phase A: 30% acetonitrile solution (pipette 300 ml of acetonitrile, dilute to 1000 ml with water, shake well); Mobile phase B: methanol; Elution was performed according to the following gradient:

[0020] Flow rate: 1.0 mL / min; Column temperature: 30°C; Detection wavelength: 230nm; Injection volume: 10 μl; Take appropriate amount of o-iodobromobenzene and its impurity reference substances, dissolve the sample in methanol, and prepare a sample solution containing 0.4 mg / mL of o-iodobromobenzene and about 4 µg / mL of its impurities. Perform HPLC analysis under the above conditions and record the chromatogram. The results are shown in the attached Figure 1 and Figure 2 , Figure 2 The chromatographic peak with a retention time of 15.001 min is o-iodobromobenzene, and the other chromatographic peaks are the chromatographic peaks of various impurities.

[0021] from Figure 1-Figure 2 It is shown that the method of the present invention can clearly separate o-iodobromobenzene from its impurities and can accurately perform detection and quantification, thereby effectively controlling the product quality of o-iodobromobenzene.

Claims

1. A method for determining related substances of DL-lactate vortioxetine intermediates, using high performance liquid chromatography, a C18 column, a certain ratio of organic phase solution-organic phase as the mobile phase, and gradient elution.

2. According to the method for analyzing and detecting related substances in the DL-lactate vortioxetine intermediate of claim 1, the organic phase is selected from one of the following compounds: methanol and acetonitrile.

3. According to the method for analyzing and detecting related substances in the DL-lactate vortioxetine intermediate of claim 1, a certain proportion of the organic phase solution is selected from one of the following inorganic salts: 10% acetonitrile, 20% acetonitrile, and 30% acetonitrile.

4. According to the method for analyzing and detecting related substances in DL-lactate vortioxetine according to claim 1, the gradient process is a gradient elution process of:

5. According to the method for analyzing and detecting related substances in the DL-lactate vortioxetine intermediate of claim 1, the chromatographic column preferably has a length of 254 mm, a diameter of 4.6 mm, and a filler particle size of 5 µm.

6. According to the method for analyzing and detecting related substances in DL-lactate vortioxetine intermediates according to claims 1 and 3, the certain proportion of organic phase solution is preferably 30% acetonitrile.

7. According to the method for analyzing and detecting related substances in the DL-vortioxetine lactate intermediate according to claims 2 and 4, the organic phase is preferably methanol.

8. The method for analyzing and detecting related substances in the DL-lactate vortioxetine intermediate according to claim 1, comprising the following steps: ① setting the flow rate to 0.5-1.5 ml / min; ② setting the detection wavelength to 220-240 nm; ③ setting the column temperature to 20-50 ° C; ④ setting the injection volume to 5-20 μl.

9. The method for analyzing and detecting related substances in the DL-lactate vortioxetine intermediate according to claim 8, wherein the chromatographic conditions are as follows: ① the flow rate is preferably 1.0 ml / min; ② the wavelength is preferably 230 nm; ③ the column temperature is preferably 30° C.; ④ the injection volume is preferably 10 μl.

10. The method for analyzing related substances in vortioxetine DL-lactate according to claim 1, wherein the related substances are: